Concepedia

Publication | Open Access

A prospective, observational study to evaluate adverse drug reactions in patients with COVID-19 treated with remdesivir or hydroxychloroquine: a preliminary report

DOIFull Paper Access

18

Citations

12

References

2021

Year

Fátima Falcão, E Viegas, Inês Carmo, Joana Soares, Mariana Solano, Patrícia Cavaco, Dina Mendes, João Rijo, Pedro Póvoa, António Pais Martins,
European Journal of Hospital Pharmacy

Abstract

Real-world data are crucial to further establish the safety profile for REM. HCQ is no longer recommended for the treatment of COVID-19.

References

YearCitations

Page 1